189 related articles for article (PubMed ID: 1842663)
1. [The diagnosis and treatment of lymphogranulomatosis in children].
Atamanov IuA; Malikov AA; Golovkina NM; Romantsova LA; Silinskaia NV
Vopr Onkol; 1991; 37(9-10):988-91. PubMed ID: 1842663
[TBL] [Abstract][Full Text] [Related]
2. [A combined therapy program for children with lymphogranulomatosis].
Poliakov VE; Ankudinov VA; Tsygankin VI; Makhonova LA
Pediatriia; 1984 Feb; (2):34-7. PubMed ID: 6546987
[No Abstract] [Full Text] [Related]
3. [Evaluation of the efficacy of radiotherapy in the combined treatment of generalized Hodgkin's disease in children].
Tsyplenkov VG; Sviridova AV
Med Radiol (Mosk); 1984 Oct; 29(10):34-7. PubMed ID: 6548787
[TBL] [Abstract][Full Text] [Related]
4. [3-year results of the combined treatment of stage I and II lymphogranulomatosis patients].
Baĭsogolov GD; Shakhtarina SV
Med Radiol (Mosk); 1984 Apr; 29(4):46-50. PubMed ID: 6546966
[TBL] [Abstract][Full Text] [Related]
5. Second malignant tumours in childhood Hodgkin's disease.
Jenkin D; Greenberg M; Fitzgerald A
Med Pediatr Oncol; 1996 Jun; 26(6):373-9. PubMed ID: 8614372
[TBL] [Abstract][Full Text] [Related]
6. [The role of radiotherapy in the treatment of Stage IIIA Hodgkin's disease in children].
Kanaev SV; Kolygin BA; Malinin AP; Chikrizov SI
Vopr Onkol; 1986; 32(9):53-6. PubMed ID: 3765524
[TBL] [Abstract][Full Text] [Related]
7. [The main stages in the complex treatment of children with lymphogranulomatosis (Hodgkin's disease)].
Poliakov VE; Tsygankin VI
Gematol Transfuziol; 1985 Oct; 30(10):38-41. PubMed ID: 3840758
[No Abstract] [Full Text] [Related]
8. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
[TBL] [Abstract][Full Text] [Related]
9. [The combined therapy of stage-II lymphogranulomatosis: the effect of splenectomy and the time period for achieving full remission on treatment efficacy].
Demina EA; Kondrat'eva NF; Pirogova NA
Ter Arkh; 1991; 63(7):40-4. PubMed ID: 1788806
[TBL] [Abstract][Full Text] [Related]
10. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Mjaaland I; Ganser D; Freitag EM; Bohndorf W
Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
[TBL] [Abstract][Full Text] [Related]
11. Treatment of stage I, IIA, IIIA1 pediatric Hodgkin disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: a Pediatric Oncology Group (POG) study.
Tebbi CK; Mendenhall N; London WB; Williams JL; de Alarcon PA; Chauvenet AR;
Pediatr Blood Cancer; 2006 Feb; 46(2):198-202. PubMed ID: 16136581
[TBL] [Abstract][Full Text] [Related]
12. [Ten-year outcomes of lymphogranulomatosis treatment according to the protocol MOPP-ABVD+radiotherapy].
Pivnik AV; Rastrigin NA; Moiseeva TN; Lutsenko IN; Dudarova RG; Shavlokhov VS; Efimov IV; Kozhurin SV; Shitareva IV; Gemdzhian EG; Tsyba NN; Kolosova LIu; Melikian AL; Skidan NI; Pan'shin GA; Sotnikov VM; Dotsenko PV; Nechistiuk AV
Ter Arkh; 2006; 78(8):57-62. PubMed ID: 17078219
[TBL] [Abstract][Full Text] [Related]
13. Pediatric Hodgkin's disease.
Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
[TBL] [Abstract][Full Text] [Related]
14. Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
Noordijk EM; Carde P; Dupouy N; Hagenbeek A; Krol AD; Kluin-Nelemans JC; Tirelli U; Monconduit M; Thomas J; Eghbali H; Aleman BM; Bosq J; Vovk M; Verschueren TA; Pény AM; Girinsky T; Raemaekers JM; Henry-Amar M
J Clin Oncol; 2006 Jul; 24(19):3128-35. PubMed ID: 16754934
[TBL] [Abstract][Full Text] [Related]
15. [Over 30-year experience of Polish Pediatric Leukemia/Lymphoma Study Group for treatment of Hodgkin's disease in children and adolescents: improvement curability and decrease of serious complications].
Balwierz W; Moryl-Bujakowska A; Depowska T; Klekawka T; Stanuch H; Matysiak M; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Raś M; Sońta-Jakimczyk D; Moszant A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Drozyńska E; Wysocki M; Kołtan A; Krawczuk-Rybak M; Stolarska M
Przegl Lek; 2004; 61 Suppl 2():33-9. PubMed ID: 15688474
[TBL] [Abstract][Full Text] [Related]
16. MOPP therapy in children with Hodgkin's disease.
Madanat FF
Am J Pediatr Hematol Oncol; 1989; 11(4):407-10. PubMed ID: 2618974
[TBL] [Abstract][Full Text] [Related]
17. [Current therapy concepts in early and intermediate stages of Hodgkin diseases in adults].
Glanzmann C; Stahel R
Praxis (Bern 1994); 1995 Oct; 84(41):1140-7. PubMed ID: 7481323
[TBL] [Abstract][Full Text] [Related]
18. [Hodgkin's disease].
Ohtake S; Nakamura S
Rinsho Ketsueki; 1989 Aug; 30(8):1193-6. PubMed ID: 2601031
[TBL] [Abstract][Full Text] [Related]
19. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.
Hudson MM; Krasin M; Link MP; Donaldson SS; Billups C; Merchant TE; Kun L; Billet AL; Kaste S; Tarbell NJ; Howard S; Friedmann AM; Hurwitz CA; Young JA; Marcus KC; Rai S; Cowan T; Weinstein HJ
J Clin Oncol; 2004 Nov; 22(22):4541-50. PubMed ID: 15542805
[TBL] [Abstract][Full Text] [Related]
20. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group.
Engert A; Schiller P; Josting A; Herrmann R; Koch P; Sieber M; Boissevain F; De Wit M; Mezger J; Duhmke E; Willich N; Muller RP; Schmidt BF; Renner H; Muller-Hermelink HK; Pfistner B; Wolf J; Hasenclever D; Loffler M; Diehl V;
J Clin Oncol; 2003 Oct; 21(19):3601-8. PubMed ID: 12913100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
